iShares Russell 2000 ETF
IWM - ETF AI Analysis
Top Page
iShares Russell 2000 ETF (IWM)
IWM, the iShares Russell 2000 ETF, has a solid overall rating that reflects a mix of strong and more challenged small-cap holdings. Standout positions like CareTrust REIT, UMB Financial, Moog, and JFrog support the fund’s quality through strong financial performance, strategic growth, and positive momentum, though often with some valuation or profitability caveats. On the weaker side, holdings such as ViaSat and BrightSpring face profitability and leverage issues, and several names show overbought technical signals, highlighting the main risk: exposure to smaller companies that can be more volatile and sensitive to financial and valuation pressures.
IWM vs. SPDR S&P 500 ETF (SPY)
- AUM
- 75.46B
- Region
- North America
- Expense Ratio
- 0.19%
- Beta
- 1.00
- Issuer
- iShares
- Inception Date
- May 22, 2000
- Dividend Yield
- 1.01%
- Asset Class
- Equity
- Index Tracked
- Russell 2000
IWM Summary
The iShares Russell 2000 ETF (IWM) is a fund that follows the Russell 2000 Index, which tracks many smaller U.S. companies across health care, finance, technology, and more. It holds hundreds of stocks, including names like JFrog and SM Energy, giving investors broad exposure to small, growing businesses that may not be household names yet. Someone might invest in IWM to diversify beyond large, well-known companies and to seek long-term growth from small caps. A key risk is that small-company stocks can be more volatile, so the value of this ETF can move up and down sharply with the market.
How much will it cost me?
This ETF has an expense ratio of 0.19%, which means you’ll pay about $1.90 per year for every $1,000 you invest. That cost is slightly higher than the cheapest broad stock index ETFs, but still reasonable, because it’s a passively managed fund tracking a more specialized small-cap index.
What would affect this ETF?
Future performance of IWM will likely benefit from a strong U.S. economy, rising demand for health care and technology, and a supportive environment for small businesses, which can help its many smaller, innovative companies grow. On the downside, higher interest rates, tighter credit conditions, or an economic slowdown in the U.S. could hurt small-cap stocks more than larger companies, especially in financials, real estate, and more cyclical areas of the market.
IWM Top 10 Holdings
IWM’s story is all about U.S. small caps, with health care, financials, and tech quietly steering the ship. Glaukos and 10x Genomics have been rising stars, giving the fund a lift as investors warm to innovative medical and genomics names, while ViaSat and SM Energy add some punch from satellite communications and energy. On the softer side, Moog and UMB Financial have seen more mixed, sometimes lagging action, keeping overall momentum in check. With all holdings U.S.-based and no single stock dominating, performance is driven by broad small-cap sentiment rather than one headline name.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Glaukos | 0.49% | $365.16M | $14.50B | 175.17% | 61Neutral | |
| JFrog | 0.40% | $298.90M | $13.70B | 84.81% | 73Outperform | |
| BrightSpring Health Services, Inc. | 0.41% | $305.67M | $14.20B | 122.67% | 67Neutral | |
| UMB Financial | 0.34% | $251.73M | $10.21B | 26.15% | 77Outperform | |
| Moog | 0.33% | $244.40M | $10.44B | 67.33% | 73Outperform | |
| TG Therapeutics | 0.32% | $237.26M | $9.49B | 104.33% | 65Neutral | |
| Jackson Financial Incorporation | 0.31% | $230.47M | $9.09B | 46.95% | 73Outperform | |
| Ryman | 0.32% | $241.18M | $9.50B | 47.30% | 66Neutral | |
| CareTrust REIT | 0.31% | $231.39M | $9.63B | 2.06% | 80Outperform | |
| Old National Bancorp Capital | 0.30% | $222.44M | $9.38B | 22.90% | 80Outperform |
IWM Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IWM, the sentiment is Negative. The current price of 269.05 is below the 20-day moving average (MA) of 278.46, below the 50-day MA of 280.23, and below the 200-day MA of 278.55, indicating a bearish trend. The MACD of -0.72 indicates Positive momentum. The RSI at 42.91 is Neutral, neither overbought nor oversold. The STOCH value of 38.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IWM.
IWM Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $269.05 | $296.00(10.02% Upside) | $75.46B | 0.19% | 63Neutral | |
| $137.00 | $168.36(22.89% Upside) | $104.47B | 0.06% | 65Neutral | |
| $282.58 | $359.72(27.30% Upside) | $78.03B | 0.03% | 66Neutral | |
| $31.96 | $42.66(33.48% Upside) | $21.71B | 0.03% | 63Neutral | |
| $108.66 | $150.57(38.57% Upside) | $16.26B | 0.06% | 61Neutral | |
| $60.76 | $77.78(28.01% Upside) | $319.49M | 0.75% | 65Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IWM | iShares Russell 2000 ETF | 269.05 | 37.97 | 16.43% | |
| IJR | iShares Core S&P Small Cap ETF | 137.00 | 24.38 | 21.64% | |
| VB | Vanguard Small-Cap ETF | 282.58 | 40.12 | 16.55% | |
| SCHA | Schwab U.S. Small-Cap ETF | 31.96 | 5.33 | 20.03% | |
| VTWO | Vanguard Russell 2000 ETF | 108.66 | 15.45 | 16.58% | |
| GSC | Goldman Sachs Small Cap Core Equity ETF | 60.76 | 9.43 | 18.37% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
